Introduction {#sec1-1}
============

Idiopathic pulmonary fibrosis (IPF) is a form of interstitial lung disease with obscured etiology and the most common primary interstitial pneumonia.\[[@ref1]\] IPF is a lung parenchyma disorder with little or no extrapulmonary manifestation.\[[@ref1]\]

The index case report is that of an adult diagnosed with IPF, who was initially treated for pulmonary tuberculosis without therapeutic response. Furthermore, this case has brought to fore diagnostic and therapeutic challenges of IPF and the need for proper evaluation.

Case Report {#sec1-2}
===========

This is a case report of a 55-year-old male textile trader who presented with complaints of breathlessness and dry cough of 3 and 2.5 years, respectively. The patient commenced antituberculosis two months before presentation, with no significant symptomatic relief. General physical examination was unremarkable. Vital signs were stable with SPO~2~ of 96% on room air. Significant chest examination finding was end-inspiratory bi-basal Velcro-like crackles. Other systemic examinations were essentially normal.

The patient\'s chest X-ray report showed streaky and patchy opacities mainly in the lower zone bilaterally \[[Figure 1](#F1){ref-type="fig"}\]. Furthermore, the patient had a chest computed tomography (CT), report of which revealed extensive tiny nodular opacities of soft-tissue density involving the entire lung fields \[[Figure 2](#F2){ref-type="fig"}\]. Lung function test showed a restrictive pattern with forced expiratory volume in 1 s (FEV1) (% predicted), forced vital capacity (FVC) (% predicted), and FEV1/FVC (% predicted) of 2.63 (3.21), 2.64 (3.92), and 99.77 (79.11), respectively.

![Anterior-posterior chest X-ray with bilateral lower zone opacities](AAM-15-204-g001){#F1}

![Axial chest computed tomography slide showing peripheral ground glass appearance with honeycombing](AAM-15-204-g002){#F2}

Following the radiological evaluation, tissue diagnosis was pursued with lung biopsy histology report showing moderate infiltration of the lung parenchyma by lymphocyte with associated patchy interstitial fibrosis and adjacent areas of normal lung tissue \[Figure [3a](#F3){ref-type="fig"} and [b](#F3){ref-type="fig"}\].

![(a) Inflammatory cell foci and adjacent normal lung parenchyma. (b) High magnification showing foci of inflammatory cell with adjacent normal lung parenchyma](AAM-15-204-g003){#F3}

After the complete evaluation, a diagnosis of interstitial lung disease, probably IPF, was entertained. He was commenced on tablet prednisolone 1 mg/kg daily, tablet rabeprazole 40 mg 12 hourly, and bone support with minimal improvement.

Discussion {#sec1-3}
==========

Clinical evaluation of the index case has re-emphasized the challenges that come with the diagnosis of IPF, especially in developing countries.\[[@ref2]\] A case series in Nigeria revealed 28.9% of 45 patients with diffuse radiological pulmonary infiltrate had cryptogenic fibrosing alveolitis, some of which were mismanaged as tuberculosis.\[[@ref3]\] There are also reported cases of IPF, some of which were initially managed as cases of smear-negative pulmonary tuberculosis.\[[@ref2][@ref4]\]

The International Consensus Statement on IPF of 2000 and the American Thoracic Society/European Respiratory Society Consensus Classification of 2002 has established criteria for the diagnosis of IPF, which was met in the index case.\[[@ref1]\] However, IPF is a clinical entity that can mimic other causes of pulmonary fibrosis and undistinguishable on the historical basis alone.\[[@ref2][@ref3]\] This diagnostic dilemma played out in the index case when it was misdiagnosed and treated as a case of pulmonary tuberculosis.

IPF typically reveals lower zone involvement with subpleural septal thickening, peripheral interstitial densities with variegation, traction bronchiectasis, honeycombing with minimal ground glass appearance on the chest CT.\[[@ref1]\] Usual interstitial pneumonia is the typical histological finding.

Treatment of patients with IPF has been challenging and disappointing. Immunosuppressants and antifibrotic agents have been the mainstay of pharmacological treatment, all of which have produced mixed clinical results.\[[@ref1][@ref5]\] Lung transplant offers a veritable option to obtain a cure of IPF but not readily available.

Conclusion {#sec1-4}
==========

IPF is associated with diagnostic and therapeutic challenges that have led to the misdiagnosis, improper treatment, and poor outcome. IPF cases have frequently treated as pulmonary tuberculosis.
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